Viking Therapeutics Correlations
VKTX Stock | USD 33.43 0.89 2.59% |
The current 90-days correlation between Viking Therapeutics and Akero Therapeutics is 0.04 (i.e., Significant diversification). The correlation of Viking Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Viking Therapeutics Correlation With Market
Average diversification
The correlation between Viking Therapeutics and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Viking |
Moving together with Viking Stock
0.82 | JNJ | Johnson Johnson | PairCorr |
0.66 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
0.91 | INZY | Inozyme Pharma | PairCorr |
0.67 | KRYS | Krystal Biotech | PairCorr |
0.65 | LPTX | Leap Therapeutics | PairCorr |
0.88 | MREO | Mereo BioPharma Group | PairCorr |
0.86 | NKTX | Nkarta Inc | PairCorr |
0.96 | PDSB | PDS Biotechnology Corp | PairCorr |
0.73 | PLRX | Pliant Therapeutics | PairCorr |
0.68 | ABBV | AbbVie Inc Earnings Call Tomorrow | PairCorr |
0.95 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.81 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.89 | AFMD | Affimed NV | PairCorr |
0.86 | AMGN | Amgen Inc Earnings Call This Week | PairCorr |
0.83 | AMLX | Amylyx Pharmaceuticals | PairCorr |
0.75 | APTO | Aptose Biosciences | PairCorr |
0.67 | STOK | Stoke Therapeutics | PairCorr |
0.79 | BDTX | Black Diamond Therap | PairCorr |
0.81 | TERN | Terns Pharmaceuticals Downward Rally | PairCorr |
0.78 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.86 | DAWN | Day One Biopharmaceu | PairCorr |
0.9 | ACET | Adicet Bio | PairCorr |
0.81 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
0.71 | WF | Woori Financial Group Earnings Call This Week | PairCorr |
Moving against Viking Stock
0.67 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
0.6 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
0.4 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
0.34 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.51 | BPMC | Blueprint Medicines Corp | PairCorr |
0.41 | PTCT | PTC Therapeutics | PairCorr |
0.92 | FNMFO | Federal National Mortgage | PairCorr |
0.71 | MNPR | Monopar Therapeutics | PairCorr |
0.69 | AVAL | Grupo Aval | PairCorr |
0.54 | TGNA | Tegna Inc | PairCorr |
0.51 | CIB | Bancolombia SA ADR Trending | PairCorr |
0.33 | DNOW | Now Inc | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Viking Stock performing well and Viking Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Viking Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ICPT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
TERN | 3.11 | (0.76) | 0.00 | (0.83) | 0.00 | 5.17 | 26.61 | |||
AKRO | 4.56 | 1.34 | 0.41 | 0.97 | 2.61 | 6.80 | 97.98 | |||
RETA | 2.22 | 0.22 | 0.03 | (0.58) | 3.31 | 5.24 | 28.80 | |||
MDGL | 3.20 | 0.77 | 0.20 | 0.99 | 3.02 | 5.74 | 33.61 | |||
SRPT | 1.84 | (0.19) | 0.00 | (0.30) | 0.00 | 3.38 | 18.92 | |||
HEPA | 6.86 | (1.09) | 0.00 | (7.92) | 0.00 | 12.31 | 86.86 | |||
PTCT | 2.35 | 0.10 | 0.03 | 0.23 | 2.46 | 5.65 | 23.75 | |||
AXSM | 2.30 | 0.26 | 0.12 | 0.42 | 1.91 | 6.33 | 16.75 | |||
IMGN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Viking Therapeutics Corporate Management
CPA CPA | Chief Officer | Profile | |
Michael Morneau | Vice Administration | Profile | |
Marianne Mancini | Chief Officer | Profile | |
Geoffrey Barker | Senior Development | Profile |